SMTL ID : 8bcy.1

HUMAN PI3KDELTA IN COMPLEX WITH COMPOUND 13

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.43 Å

Oligo State

hetero-1-1-mer

Ligands

1 x I3H: 9-[2-(3,4-dichlorophenyl)ethyl]-2-(3-hydroxyphenyl)-8-oxidanylidene-7~{H}-purine-6-carboxamide(Non-covalent)

I3H.1: 15 residues within 4Å: Chain A: F.735, M.736, P.742, L.743, W.744, I.761, D.771, Y.797, I.809, E.810, V.811, V.812, M.884, I.894, D.895 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:P.742, A:I.809, A:I.809, A:I.894, A:D.895 Hydrogen bonds: A:D.771, A:D.771, A:Y.797, A:E.810, A:V.812, A:D.895

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mazzucato, R. et al., Application of an "inhalation by design" approach to the identification and in-vitro evaluation of novel purine based PI3K delta inhibitors. Eur.J.Med.Chem. (2023)

Release Date

2023-05-10

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform: A
Phosphatidylinositol 3-kinase regulatory subunit alpha: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform

Phosphatidylinositol 3-kinase regulatory subunit alpha

Related Entries With Identical Sequence